BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 9346371)

  • 1. Thrombopoietin (Mpl ligand) and the regulation of platelet production.
    Cohen-Solal K; Debili N; Vainchenker W; Wendling F
    Eur Cytokine Netw; 1997 Sep; 8(3):311-4. PubMed ID: 9346371
    [No Abstract]   [Full Text] [Related]  

  • 2. c-mpl, the thrombopoietin receptor.
    Vainchenker W; Methia N; Debili N; Titeux M; Wendling F
    Thromb Haemost; 1995 Jul; 74(1):526-8. PubMed ID: 8578519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of thrombopoietin and related Mpl-ligands on transfusion medicine.
    Farese AM; Schiffer CA; MacVittie TJ
    Transfus Med Rev; 1997 Oct; 11(4):243-55. PubMed ID: 9345706
    [No Abstract]   [Full Text] [Related]  

  • 4. [Regulation of megakaryopoiesis and thrombopoiesis by thrombopoietin].
    Oda A; Ikeda Y
    Rinsho Byori; 1998 May; 46(5):430-4. PubMed ID: 9627493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombopoietin: the primary regulator of megakaryocyte and platelet production.
    Kaushansky K
    Thromb Haemost; 1995 Jul; 74(1):521-5. PubMed ID: 8578518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombopoietin and the humoral regulation of thrombocytopoiesis.
    Eaton DL; de Sauvage FJ
    Curr Opin Hematol; 1995 May; 2(3):167-71. PubMed ID: 9371990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombopoietin and its receptor.
    Wendling F; Vainchenker W
    Eur Cytokine Netw; 1998 Sep; 9(3):221-31. PubMed ID: 9831170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of thrombopoietin in controlling blood platelet production.
    McDonald TP; Jackson CW
    Prog Clin Biol Res; 1990; 356():219-30. PubMed ID: 2217439
    [No Abstract]   [Full Text] [Related]  

  • 9. The structure, biology and potential therapeutic applications of recombinant thrombopoietin.
    Lok S; Foster DC
    Stem Cells; 1994 Nov; 12(6):586-98. PubMed ID: 7881359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood. Thrombopoietin--at last.
    Metcalf D
    Nature; 1994 Jun; 369(6481):519-20. PubMed ID: 8202150
    [No Abstract]   [Full Text] [Related]  

  • 11. AKR-501 (YM477) a novel orally-active thrombopoietin receptor agonist.
    Fukushima-Shintani M; Suzuki K; Iwatsuki Y; Abe M; Sugasawa K; Hirayama F; Kawasaki T; Nakahata T
    Eur J Haematol; 2009 Apr; 82(4):247-54. PubMed ID: 19183407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissection of c-Mpl and thrombopoietin function: studies of knockout mice and receptor signal transduction.
    Gurney AL; de Sauvage FJ
    Stem Cells; 1996; 14 Suppl 1():116-23. PubMed ID: 11012211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombopoietin in vitro and in vivo.
    Alexander WS; Begley CG
    Cytokines Cell Mol Ther; 1998 Mar; 4(1):25-34. PubMed ID: 9557214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic deficiencies in c-mpl and TPO knockout mice.
    Murone M; Carpenter DA; de Sauvage FJ
    Stem Cells; 1998; 16(1):1-6. PubMed ID: 9474742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-3 does not contribute to platelet production in c-Mpl-deficient mice.
    Chen Q; Solar G; Eaton DL; de Sauvage FJ
    Stem Cells; 1998; 16 Suppl 2():31-6. PubMed ID: 11012175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into the regulation of megakaryocyte differentiation and platelet production derived from cloning of thrombopoietin and its receptor: surprises and unresolved questions as thrombopoietin proceeds through clinical trials.
    Jackson CW
    J Lab Clin Med; 1998 Jun; 131(6):480-4. PubMed ID: 9626981
    [No Abstract]   [Full Text] [Related]  

  • 17. Thrombopoietin-induced signal transduction and potentiation of platelet activation.
    Oda A; Miyakawa Y; Druker BJ; Ozaki K; Ohashi H; Kato T; Miyazaki H; Handa M; Ikebuchi K; Ikeda Y
    Thromb Haemost; 1999 Aug; 82(2):377-84. PubMed ID: 10605727
    [No Abstract]   [Full Text] [Related]  

  • 18. [Thrombopoietic growth factor--thrombopoietin. Molecular and biological properties].
    Skotnicki AB; Jabłoński MJ
    Przegl Lek; 1996; 53(11):826-9. PubMed ID: 9173448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The residual megakaryocyte and platelet production in c-mpl-deficient mice is not dependent on the actions of interleukin-6, interleukin-11, or leukemia inhibitory factor.
    Gainsford T; Nandurkar H; Metcalf D; Robb L; Begley CG; Alexander WS
    Blood; 2000 Jan; 95(2):528-34. PubMed ID: 10627458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-level expression of Mpl in platelets and megakaryocytes is independent of thrombopoietin.
    Cohen-Solal K; Vitrat N; Titeux M; Vainchenker W; Wendling F
    Blood; 1999 May; 93(9):2859-66. PubMed ID: 10216080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.